These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3307602)

  • 21. [Soluble interleukin-6 receptors in the serum in multiple myeloma].
    Scudla V; Kubalová D; Bacovský J; Lukes J; Vavrdová V
    Cas Lek Cesk; 1996 Nov; 135(22):719-22. PubMed ID: 8998823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Beta 2 microglobulin in some hematologic neoplasms].
    Rodríguez MA; Lira P; Foradori A; Grebe G
    Rev Med Chil; 1989 Jun; 116(6):538-42. PubMed ID: 2664940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraprotein and beta2-microglobulin analyses in multiple myeloma--do we need to monitor both?
    Sinclair D; Cranfield T; Ganczakowski M
    Clin Lab; 2003; 49(3-4):129-34. PubMed ID: 12705694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta 2 microglobulin in multiple myeloma.
    Alexanian R; Barlogie B; Fritsche H
    Am J Hematol; 1985 Dec; 20(4):345-51. PubMed ID: 3907332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial beta-2 microglobulin measurement as an auxilliary method in the early diagnosis of cytomegalovirus infection in renal transplant patients.
    Matos AC; Durão MS; Pacheco-Silva A
    Transplant Proc; 2004 May; 36(4):894-5. PubMed ID: 15194307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Beta 2 microglobulin].
    Clément F
    Schweiz Med Wochenschr; 1983 Jun; 113(23):838-43. PubMed ID: 6192496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum beta-2-microglobulin in the differential diagnosis of monoclonal gammopathies.
    Elias J; Dauth J; Senekal JC; van der Walt P; Joubert HF; Kühn F; Greenacre M
    S Afr Med J; 1991 Jun; 79(11):650-3. PubMed ID: 2047946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum beta-2-microglobulin in multiple myeloma. Practical value].
    Bataille R; Magub M; Sany J; Donadio D; Izarn P; Grenier J; Suquet P
    Rev Rhum Mal Osteoartic; 1981 Mar; 48(3):235-40. PubMed ID: 6164091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased beta 2-microglobulin (B2M) is useful in the detection of post-transplant lymphoproliferative disease (PTLD).
    Sasaki TM; Pirsch JD; D'Alessandro AM; Knechtle SJ; Kalayoglu M; Hafez GR; Sollinger HW
    Clin Transplant; 1997 Feb; 11(1):29-33. PubMed ID: 9067691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and clinical studies of serum beta 2-microglobulin levels in haematological malignancies.
    Nakao Y; Matsumoto H; Miyazaki T; Watanabe S; Masaoka T; Takatsuki K; Kishihara M; Kobayashi N; Hattori M; Fujita T
    Clin Exp Immunol; 1981 Oct; 46(1):134-41. PubMed ID: 6175458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of the assay of serum beta 2 microglobulin in the clinical evaluation of myeloma].
    Bataille R; Grenier J
    Presse Med; 1986 Oct; 15(34):1723-5. PubMed ID: 2947132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The behaviour of beta-2-microglobulin in acute and chronic leukaemias.
    Schena FP; Liso V; Losuriello V; Mera S; Bonomo L
    Biomedicine; 1980 Feb; 33(1):12-5. PubMed ID: 6154490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum beta 2 microglobulin in multiple myeloma and related plasma cell dyscrasias.
    Pasquini E; Tiraferri E; Fattori PP; Fabbri I; Gobbi M
    Haematologica; 1987; 72(1):17-21. PubMed ID: 3108090
    [No Abstract]   [Full Text] [Related]  

  • 34. [Analysis of serum beta 2-microglobulin in multiple myeloma, non-Hodgkin's malignant lymphoma and chronic lymphoid leukemia].
    Balikó Z; Tornóczky J; Pasztarak E; Tóth A; Muth L
    Orv Hetil; 1983 Jan; 124(3):131-4. PubMed ID: 6188088
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical studies on serum beta2-microglobulin in multiple myeloma and other related diseases (author's transl)].
    Nishioka F; Yachi A; Wada T
    Rinsho Ketsueki; 1978 Feb; 19(2):100-6. PubMed ID: 77342
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of alpha-interferon on serum beta-2-microglobulin.
    Remes K; Tienhaara A; Pelliniemi TT
    Leuk Lymphoma; 1996 Apr; 21(3-4):233-8. PubMed ID: 8726404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.
    Kyrtsonis MC; Vassilakopoulos TP; Siakantaris MP; Kokoris SI; Gribabis DA; Dimopoulou MN; Angelopoulou MK; Pangalis GA
    Eur J Haematol; 2004 Apr; 72(4):252-8. PubMed ID: 15089762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro production of beta 2 microglobulin by human myeloma cells.
    Bataille R; Grenier J; Commes T
    Cancer Invest; 1988; 6(3):271-7. PubMed ID: 3048575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-2-microglobulin in multiple myeloma.
    Musarurwa C; Matarira HT
    Cent Afr J Med; 2004; 50(1-2):19-20. PubMed ID: 15490720
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma cell growth fraction using Ki-67 antigen expression identifies a subgroup of multiple myeloma patients displaying short survival within the ISS stage I.
    Gastinne T; Leleu X; Duhamel A; Moreau AS; Franck G; Andrieux J; Lai JL; Coiteux V; Yakoub-Agha I; Bauters F; Harousseau JL; Zandecki M; Facon T;
    Eur J Haematol; 2007 Oct; 79(4):297-304. PubMed ID: 17692103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.